OCUL - OCULAR THERAPEUTIX, INC

QQQ $ 431.01 $ 6.55 (1.54 %)

DIA $ 382.27 $ 1.39 (0.36 %)

SPY $ 508.26 $ 4.77 (0.95 %)

TLT $ 88.26 $ 0.46 (0.52 %)

GLD $ 216.60 $ 0.70 (0.32 %)

Previous Close

$ 4.745

Open

$ 4.09

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 4.09 - $ 4.78

52 Week Range

$ 2.00 - $ 11.31

Volume

3,883,481

Average Volume

Market Cap

406.16M

Beta (5Y Monthly)

$ 1.47

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-11-2024	12-31-2023	10-K
2	11-07-2023	09-30-2023	10-Q
3	08-07-2023	06-30-2023	10-Q
4	05-08-2023	03-31-2023	10-Q
5	03-06-2023	12-31-2022	10-K
6	11-07-2022	09-30-2022	10-Q
7	08-08-2022	06-30-2022	10-Q
8	05-09-2022	03-31-2022	10-Q
9	02-28-2022	12-31-2021	10-K
10	11-08-2021	09-30-2021	10-Q
11	08-09-2021	06-30-2021	10-Q
12	05-05-2021	03-31-2021	10-Q
13	03-11-2021	12-31-2020	10-K
14	11-05-2020	09-30-2020	10-Q
15	08-07-2020	06-30-2020	10-Q
16	05-08-2020	03-31-2020	10-Q
17	03-12-2020	12-31-2019	10-K
18	11-12-2019	09-30-2019	10-Q
19	08-07-2019	06-30-2019	10-Q
20	05-10-2019	03-31-2019	10-Q
21	03-07-2019	12-31-2018	10-K
22	11-07-2018	09-30-2018	10-Q
23	08-07-2018	06-30-2018	10-Q
24	05-08-2018	03-31-2018	10-Q
25	03-08-2018	12-31-2017	10-K
26	11-07-2017	09-30-2017	10-Q
27	08-08-2017	06-30-2017	10-Q
28	05-05-2017	03-31-2017	10-Q
29	03-10-2017	12-31-2016	10-K
30	11-09-2016	09-30-2016	10-Q
31	08-09-2016	06-30-2016	10-Q
32	05-10-2016	03-31-2016	10-Q
33	03-10-2016	12-31-2015	10-K
34	11-10-2015	09-30-2015	10-Q
35	08-10-2015	06-30-2015	10-Q
36	05-15-2015	03-31-2015	10-Q
37	03-20-2015	12-31-2014	10-K
38	11-12-2014	09-30-2014	10-Q
39	08-29-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Why Super Micro Computer Shares Are Tradin...
04/19/2024 17:25:08

HC Wainwright & Co. Reiterates Buy on Ocul...
04/19/2024 10:28:57

HC Wainwright & Co. analyst Yi Chen reiterates Ocular Therapeutix (NASDAQ:OCUL) with a Buy and maintains $16 price target.

ocular-therapeutix-highlights-early-data-from-diabetes-related-eye-disorder

Ocular Therapeutix Highlights Early Data F...
04/18/2024 17:37:05

Ocular Therapeutix's Phase 1 HELIOS study unveils Axpaxli's efficacy in treating non-proliferative diabetic retinopathy...

why-las-vegas-sands-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-thursdays-mid-day-session

Why Las Vegas Sands Shares Are Trading Low...
04/18/2024 15:32:50

Ocular Therapeutix Reports Topline Phase 1...
04/18/2024 11:03:06

Ocular plans to present the study results at an upcoming meeting. AXPAXLI was generally well tolerated with no inflammation obs...

The Analyst Verdict: Ocular Therapeutix In...
04/16/2024 17:01:36

JMP Securities Reiterates Market Outperfor...
04/16/2024 15:13:37

JMP Securities analyst Jonathan Wolleben reiterates Ocular Therapeutix (NASDAQ:OCUL) with a Market Outperform and maintains ...

Ocular Therapeutix Announced That Executiv...
04/15/2024 11:27:30

Reported Saturday, Ocular Therapeutix™ Ann...
04/08/2024 07:27:18

Phase 2 data highlight consistent and sustained reductions in Intraocular Pressure (IOP), statistically significant (p<0.0...

JMP Securities Reiterates Market Outperfor...
03/13/2024 15:34:33

JMP Securities analyst Jonathan Wolleben reiterates Ocular Therapeutix (NASDAQ:OCUL) with a Market Outperform and maintains ...

Decoding 6 Analyst Evaluations For Ocular ...
03/13/2024 12:01:19

HC Wainwright & Co. Maintains Buy on Ocula...
03/13/2024 10:46:45

HC Wainwright & Co. analyst Yi Chen maintains Ocular Therapeutix (NASDAQ:OCUL) with a Buy and raises the price target fr...

Why Asana Shares Are Trading Lower By 11%?...
03/12/2024 18:07:31

Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance.

these-analysts-boost-their-forecasts-on-ocular-therapeutix-after-q4-results

These Analysts Boost Their Forecasts On Oc...
03/12/2024 16:42:09

Ocular Therapeutix, Inc. (NASDAQ: OCUL) reported worse-than-expected fourth-quarter financial results on Monday.

TD Cowen Maintains Market Perform on Ocula...
03/12/2024 15:53:56

TD Cowen analyst Tara Bancroft maintains Ocular Therapeutix (NASDAQ:OCUL) with a Market Perform and raises the price target ...

JMP Securities Maintains Market Outperform...
03/12/2024 14:10:25

JMP Securities analyst Jonathan Wolleben maintains Ocular Therapeutix (NASDAQ:OCUL) with a Market Outperform and raises the ...

Why Oracle Shares Are Trading Higher By Ar...
03/12/2024 12:11:02

Shares of Oracle Corporation (NYSE: ORCL) rose sharply in today’s pre-market trading after the company reported upbeat earning...

acadia-pharmaceuticals-ocular-therapeutix-asana-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session

ACADIA Pharmaceuticals, Ocular Therapeutix...
03/12/2024 09:36:05

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 50 points on Tuesday.

12-health-care-stocks-moving-in-mondays-after-market-session

12 Health Care Stocks Moving In Monday's A...
03/11/2024 21:34:44

Ocular Therapeutix: Q4 Earnings Insights
03/11/2024 20:15:18